S. 5059 · 119th Congress · Health

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

In committee31 words Introduced Jul 21, 2026 · Latest action Jul 21, 2026

How far it has goneStage 2 of 6
  1. IntroducedJul 21, 2026 Done
  2. CommitteeReferred to Health, Education, Labor, and Pensions Current stage
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 31 words

S. 5059 · Introduced in Senate · Jul 21, 2026

SECTION 1. STREAMLINING BIOSIMILAR REVIEWS.

Section 351(k)(5) of the Public Health Service Act ( 42 U.S.C. 262(k)(5) ) is amended— (1) by striking subparagraph (B); and (2) by redesignating subparagraph (C) as subparagraph (B).

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

1 organization · 1 filing · Q3 2026

See which of this bill’s sponsors and cosponsors got money from America's Health Insurance Plans Inc (ahip)’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. America's Health Insurance Plans Inc (ahip) 1 of 1 quarter
    “…S. 5059 - A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products. - Sen. Moody, Ashley - Biosimilar and biological product review process Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; cost-sharing and coverage of weight loss…”

    $11.3M lobbying spend in 2026 to date, all issuesQ3 2026 filing

Organizations that named S. 5059 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jul 21, 2026Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Jul 21, 2026Introduced in Senate